Hyfusin Group Holdings Limited (8512.HK)
HKD 0.29
(-1.69%)
HKD 0.29
(-1.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 154.18 Million HKD | 49.16% |
| 2022 | 109.2 Million HKD | -24.65% |
| 2021 | 144.92 Million HKD | 18.13% |
| 2020 | 122.68 Million HKD | 203.21% |
| 2019 | 40.46 Million HKD | 249.68% |
| 2018 | 11.57 Million HKD | 345.83% |
| 2017 | -6.53 Million HKD | -129.18% |
| 2016 | 13.7 Million HKD | -14.88% |
| 2015 | 18.91 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 38.61 Million HKD | 0.0% |
| 2024 Q1 | 38.61 Million HKD | 385.35% |
| 2023 FY | - HKD | 49.16% |
| 2023 Q4 | -7.27 Million HKD | -108.92% |
| 2023 Q1 | 27.23 Million HKD | 4.95% |
| 2023 Q2 | 48.75 Million HKD | 79.03% |
| 2023 Q3 | 81.54 Million HKD | 67.26% |
| 2022 Q1 | 24.23 Million HKD | -38.82% |
| 2022 FY | - HKD | -24.65% |
| 2022 Q4 | 25.94 Million HKD | 10.13% |
| 2022 Q3 | 23.56 Million HKD | -7.83% |
| 2022 Q2 | 25.56 Million HKD | 5.47% |
| 2021 Q1 | 23.54 Million HKD | -51.66% |
| 2021 Q2 | 41.48 Million HKD | 76.17% |
| 2021 Q3 | 34.8 Million HKD | -16.11% |
| 2021 Q4 | 39.61 Million HKD | 13.84% |
| 2021 FY | - HKD | 18.13% |
| 2020 Q2 | 8.53 Million HKD | -19.21% |
| 2020 Q1 | 10.55 Million HKD | -45.17% |
| 2020 Q3 | 48.5 Million HKD | 468.61% |
| 2020 Q4 | 48.7 Million HKD | 0.41% |
| 2020 FY | - HKD | 203.21% |
| 2019 Q4 | 19.25 Million HKD | 24.74% |
| 2019 FY | - HKD | 249.68% |
| 2019 Q3 | 15.43 Million HKD | 3456.3% |
| 2019 Q2 | -460 Thousand HKD | -351.37% |
| 2019 Q1 | 183 Thousand HKD | -92.77% |
| 2018 Q3 | 6.18 Million HKD | 207.26% |
| 2018 Q1 | -1.69 Million HKD | 73.05% |
| 2018 Q4 | 2.53 Million HKD | -59.06% |
| 2018 FY | - HKD | 345.83% |
| 2018 Q2 | 2.01 Million HKD | 218.63% |
| 2017 Q3 | 6 Million HKD | 303.73% |
| 2017 Q1 | 187.5 Thousand HKD | 0.0% |
| 2017 Q2 | -2.94 Million HKD | -1671.2% |
| 2017 Q4 | -6.29 Million HKD | -204.83% |
| 2017 FY | - HKD | -129.18% |
| 2016 FY | - HKD | -14.88% |
| 2015 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 22.91 Million HKD | -572.953% |
| Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | 51.475% |
| China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -7499.162% |
| Prosperous Future Holdings Limited | -19.68 Million HKD | 883.232% |
| Huasheng International Holding Limited | 19.67 Million HKD | -683.55% |
| Fourace Industries Group Holdings Limited | 61.52 Million HKD | -150.609% |
| Evergreen Products Group Limited | 140.78 Million HKD | -9.522% |
| EC Healthcare | 737.83 Million HKD | 79.103% |
| Ming Fai International Holdings Limited | 211.83 Million HKD | 27.213% |
| Blue Moon Group Holdings Limited | 656.37 Million HKD | 76.509% |
| SuperRobotics Holdings Limited | -7.39 Million HKD | 2183.89% |
| Takbo Group Holdings Limited | 25.8 Million HKD | -497.531% |